Abbott’s Lingo Becomes Second FDA-Cleared OTC Blood Glucose Monitor

The FDA has given the green light to over-the-counter sales of Abbott’s Lingo blood glucose monitoring device, which is intended for use by healthy people who want to track the crucial biomarker.

Lingo, line of consumer biowearables to measure glucose, ketones and lactate
• Source: Abbott

More from Approvals

More from Policy & Regulation